This study demonstrated that CDR1as overexpression is associated with adverse chemotherapeutic effects and that CDR1as competitive inhibition of miR‐7 enhanced the sensitivity of drug‐resistant breast cancer cells to cisplatin. The gene discussed is LINC00632; the disease is breast cancer.